Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
64.3M
-
Shares change
-
+2.8M
-
Total reported value, excl. options
-
$258M
-
Value change
-
+$14.7M
-
Put/Call ratio
-
0.14
-
Number of buys
-
40
-
Number of sells
-
-37
-
Price
-
$4.01
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q3 2019
96 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q3 2019.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.3M shares
of 170M outstanding shares and own 37.73% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (21.6M shares), Sumitomo Mitsui Trust Holdings, Inc. (7.66M shares), Nikko Asset Management Americas, Inc. (7.66M shares), FMR LLC (7.15M shares), ARK Investment Management LLC (7.07M shares), BlackRock Inc. (4M shares), VANGUARD GROUP INC (2.09M shares), RENAISSANCE TECHNOLOGIES LLC (1.08M shares), JPMORGAN CHASE & CO (592K shares), and STATE STREET CORP (573K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.